The molecular characterization and therapeutic strategies of papillary renal cell carcinoma
Author:
Affiliation:
1. Department of Urology, First Affiliated Hospital of Dalian Medical University, Dalian, China
2. Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Oncology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14737140.2019.1548939
Reference66 articles.
1. Treatment of renal cell carcinoma: Current status and future directions
2. Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi-institutional study on 2189 patients
3. Differential prognostic value of MYC immunohistochemistry in subtypes of papillary renal cell carcinoma
4. MicroRNA profiles classify papillary renal cell carcinoma subtypes
5. Prediction and preliminary validation of oncogene regulation by miRNAs
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Classification OMS 2022 des cancers du rein : focus sur le carcinome rénal papillaire;Annales de Pathologie;2024-09
2. Integrated Bioinformatics and Experimental Validation to Identify a Disulfidptosis-Related lncRNA Model for Prognostic Prediction in Papillary Renal Cell Carcinoma;Combinatorial Chemistry & High Throughput Screening;2024-04-18
3. Free-fatty acid receptor-1 (FFA1/GPR40) promotes papillary RCC proliferation and tumor growth via Src/PI3K/AKT/NF-κB but suppresses migration by inhibition of EGFR, ERK1/2, STAT3 and EMT;Cancer Cell International;2023-06-24
4. Identification of Five Tumor Antigens for Development and Two Immune Subtypes for Personalized Medicine of mRNA Vaccines in Papillary Renal Cell Carcinoma;Journal of Personalized Medicine;2023-02-18
5. Identification of basement membrane-related prognostic signature for predicting prognosis, immune response and potential drug prediction in papillary renal cell carcinoma;Mathematical Biosciences and Engineering;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3